140 related articles for article (PubMed ID: 34409955)
1. Hepatosplenic T-cell lymphoma: treatment challenges.
Bron D; De Leval L; Michiels S; Wittnebel S;
Curr Opin Oncol; 2021 Sep; 33(5):406-411. PubMed ID: 34409955
[TBL] [Abstract][Full Text] [Related]
2. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience.
Voss MH; Lunning MA; Maragulia JC; Papadopoulos EB; Goldberg J; Zelenetz AD; Horwitz SM
Clin Lymphoma Myeloma Leuk; 2013 Feb; 13(1):8-14. PubMed ID: 23107915
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and treatment outcomes of 14 patients with hepatosplenic γ δ T-cell lymphoma.
Wang Q; Jiang Y; Zhu Q; Duan Y; Chen X; Xu T; Jin Z; Li C; Wu D; Huang H
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3441-3445. PubMed ID: 33856526
[TBL] [Abstract][Full Text] [Related]
4. Hepatosplenic γδ T-cell lymphoma of two adolescents: Case report and retrospective literature review in children, adolescents, and young adults.
McThenia SS; Rawwas J; Oliveira JL; Khan SP; Rodriguez V
Pediatr Transplant; 2018 Aug; 22(5):e13213. PubMed ID: 29921021
[TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic T-cell lymphoma in a young man with Crohn's disease: case report and literature review.
Ochenrider MG; Patterson DJ; Aboulafia DM
Clin Lymphoma Myeloma Leuk; 2010 Apr; 10(2):144-8. PubMed ID: 20371449
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases.
Yabe M; Medeiros LJ; Tang G; Wang SA; Ahmed S; Nieto Y; Hu S; Bhagat G; Oki Y; Patel KP; Routbort M; Luthra R; Fanale MA; Bueso-Ramos CE; Jorgensen JL; Vega F; Chen W; Hoehn D; Konoplev S; Milton DR; Wistuba I; Li S; You MJ; Young KH; Miranda RN
Am J Surg Pathol; 2016 May; 40(5):676-88. PubMed ID: 26872013
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
Bojanini L; Jiang L; Tun AJ; Ayala E; Menke DM; Hoppe B; Kharfan-Dabaja MA; Tun HW; Alhaj Moustafa M
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):106-112.e1. PubMed ID: 33160933
[TBL] [Abstract][Full Text] [Related]
8. Refractory hepatosplenic T-cell lymphoma was successfully treated with salvage allogeneic hematopoietic stem cell transplantation combined with enhanced myeloablative preconditioning.
Huang W; Xue S; Zhang Y; Liu F; Tian M; Wang Y; Li F; Lu Y; Wang J
Ann Hematol; 2023 Jan; 102(1):175-180. PubMed ID: 36355191
[TBL] [Abstract][Full Text] [Related]
9. Sustained first remission in an adolescent with hepatosplenic T-cell lymphoma treated with T-cell leukemia induction, nucleoside analog-based consolidation, and early hematopoietic stem cell transplant.
Schafer E; Chen A; Arceci RJ
Pediatr Blood Cancer; 2009 Dec; 53(6):1127-9. PubMed ID: 19479793
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract][Full Text] [Related]
11. Successful Bridging Chemotherapy with Gemcitabine, Carboplatin, and Dexamethasone before Unrelated Stem Cell Transplantation for Hepatosplenic T-cell Lymphoma.
Okuni M; Yakushijin K; Uehara K; Ichikawa H; Suto H; Hashimoto A; Tanaka Y; Shinzato I; Sakai R; Mizutani Y; Nagao S; Kurata K; Kakiuchi S; Miyata Y; Inui Y; Saito Y; Kawamoto S; Yamamoto K; Ito M; Matsuoka H; Minami H
Intern Med; 2019 Mar; 58(5):707-712. PubMed ID: 30449784
[TBL] [Abstract][Full Text] [Related]
12. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
Yabe M; Miranda RN; Medeiros LJ
Hum Pathol; 2018 Apr; 74():5-16. PubMed ID: 29337025
[TBL] [Abstract][Full Text] [Related]
13. Successful second allogeneic stem-cell transplantation from the same sibling donor for a patient with recurrent hepatosplenic gamma-delta (γ/δ) T-cell lymphoma: A case report.
Pan H; Huang J; Li JN; Yang L; Wang JY; Wang X; Liu L; Yang ZS; Wang L
Medicine (Baltimore); 2018 Nov; 97(44):e12941. PubMed ID: 30383643
[TBL] [Abstract][Full Text] [Related]
14. Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.
Gasljevic G; Kloboves-Prevodnik V; Gazic B; Vovk M
Diagn Pathol; 2014 Mar; 9():58. PubMed ID: 24621139
[TBL] [Abstract][Full Text] [Related]
15. Hepatosplenic T-cell lymphoma and inflammatory bowel disease.
Thai A; Prindiville T
J Crohns Colitis; 2010 Nov; 4(5):511-22. PubMed ID: 21122554
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma.
Chanan-Khan A; Islam T; Alam A; Miller KC; Gibbs J; Barcos M; Czuczman MS; Paplham P; Hahn T; McCarthy P
Leuk Lymphoma; 2004 Aug; 45(8):1673-5. PubMed ID: 15370223
[TBL] [Abstract][Full Text] [Related]
17. [Microcellular lung carcinoma in patient with hepatosplenic T-cell lymphoma: a case report].
Kalac M; Ostojić S; Gasparov S; Planinc-Peraica A; Dominis M; Jaksić B
Lijec Vjesn; 2006; 128(3-4):76-8. PubMed ID: 16808095
[TBL] [Abstract][Full Text] [Related]
18. Persistent non-neoplastic gammadelta-T cells in cerebrospinal fluid of a patient with hepatosplenic (gammadelta) T cell lymphoma: a case report with 6 years of flow cytometry follow-up.
Jiang L; Abati AD; Wilson W; Stetler-Stevenson M; Yuan C
Int J Clin Exp Pathol; 2009 Oct; 3(1):110-6. PubMed ID: 19918335
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic bone marrow transplantation for chemotherapy-refractory hepatosplenic gammadelta T-cell lymphoma: case report and review of the literature.
Domm JA; Thompson M; Kuttesch JF; Acra S; Frangoul H
J Pediatr Hematol Oncol; 2005 Nov; 27(11):607-10. PubMed ID: 16282893
[TBL] [Abstract][Full Text] [Related]
20. Hepatosplenic gammadelta T-cell lymphoma: complete response induced by treatment with pentostatin.
Iannitto E; Barbera V; Quintini G; Cirrincione S; Leone M
Br J Haematol; 2002 Jun; 117(4):995-6. PubMed ID: 12060145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
